A government-backed trial will take exam results digital, but some say this could “take away a rite of passage”.Read More
You might also be interested in reading BioHarvest outlines path to $11M–$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline.
